Mental Stress and Myocardial Ischemia After MI: Sex Differences, Mechanisms and Prognosis

Not Applicable

Active, not recruiting

• Conditions: Myocardial Infarction
• Interventions: Other: Stress Challenge

• Registration Number: NCT04123197
• Lead Sponsor: Emory University

Brief Summary

The purpose of this study is to look at the link between emotional stress and heart disease in men and women. Taking part in this study involves one clinic visit, one week of at home monitoring, and follow up phone calls every 6 months for 3 years.

Detailed Description

In the U.S. and globally, coronary heart disease (CHD) is the number one killer of women. Despite scientific advances, it is unclear whether the pathophysiology of CHD differs between women and men. The study of CHD in women has historically been centered on older women, however, women with early onset CHD are informative for the study of early risk factors and pathophysiology. Furthermore, young women with a myocardial infarction (MI) have emerged as a group in need of special study as this group has higher mortality compared with men of similar age despite less severe disease. These disparities remain unexplained and suggest sex differences in the pathophysiology, risk factors and prognostic factors of acute MI.

The psychosocial sphere is a largely neglected area for CHD prevention in women. Social and emotional exposures mostly beginning early in life (depression, early life adversities, poverty and posttraumatic stress symptoms) are more common in younger women with MI compared with men and community controls. In addition to being more prevalent, it is possible that emotional stress is a stronger risk factor in young women than other groups. A significant challenge, however, is to measure stress in a valid way.

Building on previous work, the current project will clarify sex differences in pathways of risk linking emotional stress to mental stress-induced myocardial ischemia (MSI) and cardiovascular outcomes in young post-MI patients. Within 8 months of MI, 310 patients ≤60 years of age (at the time of the MI), 50% women, will be tested in the lab with a stress challenge to asses MSI using an established protocol with myocardial perfusion imaging. Participants will be monitored at home for 1 week, and then followed for clinical events for 3 years.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2019-10-09
• Study First Submitted QC: 2019-10-09
• Study First Posted: 2019-10-10
• Study Start: 2020-02-28
• Status Verified: 2024-07
• Last Update Submitted: 2024-07-11
• Last Update Posted: 2024-07-15
• Primary Completion: 2025-07-31
• Study Completion: 2025-07-31

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 311

Inclusion Criteria

• History of documented MI within the past 8 months
• Age ≤60 at the time of MI

Read More

Exclusion Criteria

• History of unstable angina, MI, or decompensated heart failure in the past month
• Patients deemed to be unsafe to hold anti-ischemic medications before testing (it is standard protocol to hold these meds before imaging studies)
• Systolic blood pressure (SBP) >180 mm Hg or diastolic blood pressure (DBP) >110 mm Hg on the day of the test
• Alcohol or substance abuse (past year), or severe psychiatric disorder other than major depression
• Other serious medical disorders that may interfere with the study results
• Postmenopausal hormone therapy (past 3 months)
• Current psychotropic medications (past month) except anti-depressants
• Pregnancy or breastfeeding (all women will receive a pregnancy test)
• Severe aortic stenosis
• Weight ≥ 360 pounds and/or body mass index (BMI) of 40 or greater (weight limit of the SPECT imaging table)

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Young Participants with Prior MI	Stress Challenge	Participants aged 60 or less who experienced a MI within the last 8 months will undergo a stress challenge to assess MSI and will then be followed for 3 years.

Primary Outcome Measures

Name	Time	Method
Cardiovascular Events	3 Years	The main outcome will be a composite endpoint of recurrent MI, unstable angina, hospitalization for decompensated heart failure, and cardiovascular (CV) death. A mental stress-induced myocardial ischemia (MSI) status of positive or negative will be the main predictor in regression models.

Secondary Outcome Measures

Name	Time	Method
Cardiovascular Death	3 Years	The number of participants experiencing CV death in relation to MSI status (positive or negative).
Total Mortality	3 Years	The number of participants experiencing all-cause death in relation to MSI status (positive or negative).
Myocardial Infarction or Cardiovascular Death	3 Years	The number of participants experiencing myocardial infarction or CV death in relation to MSI status (positive or negative).
Cardiovascular Events Excluding Heart Failure	3 Years	This is a composite endpoint of recurrent MI, unstable angina, or CV death where the number of participants experiencing this endpoint in relation to MSI status (positive or negative) will be examined.

Trial Locations

Locations (3)

Emory University Hospital; 🇺🇸 Atlanta, Georgia, United States

The Emory Clinic; 🇺🇸 Atlanta, Georgia, United States

Grady Health System; 🇺🇸 Atlanta, Georgia, United States